Zhejiang, China

Jiankang Zhang

This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Zhejiang University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiankang Zhang. Retrieved from https://idiyas.com/inventor/jiankang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jiankang Zhang

Introduction

Jiankang Zhang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of anti-tumor drug development through his innovative research and patents. His work exemplifies the intersection of science and practical application in medicine.

Latest Patents

Jiankang Zhang holds a patent for a tripeptide epoxyketone compound constructed by heterocycle, along with its preparation method and use. This patent focuses on the development of a compound that can be utilized in the preparation of anti-tumor drugs. His innovative approach has the potential to advance cancer treatment options significantly.

Career Highlights

Throughout his career, Jiankang Zhang has been associated with prestigious institutions such as Zhejiang University and the Chinese Academy of Sciences. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jiankang Zhang has worked alongside notable colleagues, including Yongzhou Hu and Jia Tao Li. Their combined expertise has fostered an environment of innovation and discovery, leading to advancements in their respective fields.

Conclusion

Jiankang Zhang's contributions to the field of anti-tumor drug development through his patent and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in medical research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…